Year and age at diagnosis | ||||||||||||||||
2008/10 | 2010/12 | 2012/14 | 2014/16 | 2016/18 | ||||||||||||
65–74 | 75–84 | 85+ | 65–74 | 75–84 | 85+ | 65–74 | 75–84 | 85+ | 65–74 | 75–84 | 85+ | 65–74 | 75–84 | 85+ | ||
No. of patients in cohort (no. anticoagulated) | 2008/10 | 2673 (1482) | 4339 (2339) | 2528 (679) | – | – | – | – | – | – | – | – | – | – | – | – |
2010/12 | 2410 (1461) | 3749 (2279) | 1858 (601) | 2999 (1796) | 4940 (2872) | 2892 (1001) | – | – | – | – | – | – | – | – | – | |
2012/14 | 1967 (1284) | 2811 (1797) | 1073 (374) | 2712 (1806) | 4243 (2800) | 2128 (904) | 2869 (2027) | 4736 (3290) | 2830 (1370) | – | – | – | – | – | – | |
2014/16 | 1322 (940) | 1671 (1201) | 462 (206) | 1829 (1309) | 2604 (1842) | 981 (504) | 2275 (1778) | 3589 (2727) | 1807 (1098) | 2091 (1691) | 3368 (2696) | 2104 (1407) | – | – | – | |
2016/18 | 565 (437) | 667 (498) | 102 (56) | 833 (631) | 1002 (755) | 280 (162) | 1055 (840) | 1502 (1206) | 541 (354) | 1331 (1125) | 1991 (1686) | 1041 (757) | 1090 (937) | 1672 (1430) | 1159 (865) |